No Data
Here's the Major Earnings Before the Open Tomorrow
InflaRx Q3 2024 Earnings Preview
Earnings Preview: InflaRx to Report Financial Results Pre-market on November 08
$InflaRx(IFRX.US)$ is scheduled to release its financial results pre-market on November 08 ET. Earnings PreviewAnalysts estimate $InflaRx(IFRX.US)$ to post revenue of EUR15.50K for 2024Q3, down 74.51%
InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference
H.C. Wainwright Maintains InflaRx(IFRX.US) With Buy Rating, Maintains Target Price $8
InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress
No Data
No Data